Single Guide vs Two Guide vs XDel: Which CRISPR Knockout Strategy Is Right for Your Experiment?

Knockout, XDel | July 1, 2026 | By Amir Bolandparvaz
Single Guide vs Two Guide vs XDel: Which CRISPR Knockout Strategy Is Right for Your Experiment?
Share

Application Note: XDel CRISPR Knockouts: Sustained Protein Depletion & Simplified Genotyping

Get the Full XDel App Note
Not All CRISPR Kits Are Created Equal: How to Choose the Right Knockout Kit
crispr

Not All CRISPR Kits Are Created Equal: How to Choose the Right Knockout Kit

How Does CRISPR Work to Knock Out Genes CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a powerful gene editing tool originally derived from bacterial immune systems. It acts as a pair of molecular scissors, allowing scientists to precisely cut and rewrite DNA at specific locations. The system is composed of two main components: A Cas (CRISPR-associated) nuclease that cuts DNA A guide RNA (gRNA) that directs the nuclease to the target sequence Figure 1. The CRISPR-Cas9 System. The CRISPR-Cas9 system comprises a guide RNA (gRNA) and Cas9 nuclease, which together form a ribonucleoprotein (RNP) complex. The presence of a specific protospacer adjacent motif (PAM) in the genomic DNA is required for the gRNA to bind to the target sequence. The Cas9 nuclease then makes a double strand break in the DNA (denoted by the scissors). Endogenous repair mechanisms triggered by the double strand break may result in gene knockout via a frameshift mutation or knock-in of a desired sequence if a DNA template is present. By leveraging this simple yet powerful system, researchers can edit genomes with unprecedented ease, enabling breakthroughs in areas such as disease modeling, drug discovery, and personalized medicine. When Cas9 introduces a double-stranded break (DSB), cells typically repair the damage via non-homologous end joining (NHEJ), a process that often introduces insertions or deletions (indels). If these indels occur in the coding region and result in a frameshift, the gene is functionally knocked out. Gene knockout is foundational in modern biology. And while CRISPR has made knockout experiments more accessible, not all kits on the market deliver the same results. Whether you’re just starting out or scaling up a high-throughput workflow, choosing the right CRISPR kit can make or break your experiment. Figure 2. CRISPR knockout through non-homologous end joining (NHEJ) . The two most common repair mechanisms facilitating CRISPR-Cas editing are nonhomologous end joining (NHEJ) and homology-directed repair (HDR). NHEJ results in either insertions or deletions of nucleotides to repair the DSB, creating a frameshift mutation and effectively knocking out the gene.

Read More
CRISPR Confidence: The Power of Controls in Genome Editing
CRISPR Screening

CRISPR Confidence: The Power of Controls in Genome Editing

Key Takeaways CRISPR controls are essential for optimizing editing efficiency, validating phenotypes, and improving experimental reproducibility. Positive, negative, AAVS1, and lethal controls each serve distinct purposes throughout CRISPR workflows. CRISPR controls are widely used in functional genomics, pooled and arrayed screening, stem cell engineering, and drug discovery. EditCo provides validated CRISPR control reagents compatible with immortalized, primary, and iPSC models. Common CRISPR Control Types and Their Applications CRISPR genome editing is transforming biological research, and experimental controls are the backbone of reliable, reproducible results. In this article, we explore the essential role of CRISPR controls and supporting reagents in optimizing editing efficiency, troubleshooting workflows, and ensuring consistency across experiments. Whether you’re editing immortalized cells , iPSCs , or primary cells , CRISPR positive and negative controls are key to unlocking the full potential of your gene editing experiments. Why CRISPR Controls Matter CRISPR controls are not just “nice to have” — they are fundamental to every step of a genome editing experiment: Optimization: Use controls to fine-tune transfection parameters and editing protocols across different cell types and workflows. Controls help establish optimal conditions before investing in gene-specific reagents. Assay Development : Optimize transfection conditions and editing performance before targeting your gene of interest. Screening and Validation : Confirm editing efficiency and distinguish true biological effects from technical artifacts. Troubleshooting : Identify potential problems with delivery, reagent performance, or cell health. Without appropriate controls, even the most promising CRISPR screen can yield ambiguous or misleading results.

Read More
CRISPR and AI in Drug Discovery: Finding the Needle in the Genomic Haystack
Target Identification

CRISPR and AI in Drug Discovery: Finding the Needle in the Genomic Haystack

Over the past decade, CRISPR gene-editing technology and artificial intelligence (AI) have emerged as transformative forces in biomedical research. Independently, each has driven significant progress in understanding and treating diseases. However, when integrated, these technologies create a synergistic paradigm that is accelerating drug discovery and the development of targeted therapies. The precision of CRISPR, coupled with AI’s capacity to analyze vast biological datasets, is streamlining the identification of novel drug targets, optimizing genetic modifications, and facilitating the design of personalized treatments with unprecedented accuracy and efficiency.

Read More